Biosensing Takes A Leap With Synex Medical

Biosensing Takes A Leap With Synex Medical

Biosensing is the main component of the future personal area network. The Apple Watch is the most widely known biosensing device. The latest version (Series 6, released September 2020) sparkles with features that lean perpetually towards health including a class II FDA clearance for electrocardiogram for atrial fibrillation (AFib) detection and wellness-grade daily blood oxygen … Read more

Here Is A PIPE & SPAC Combo In The Proteomics Space

Here Is A PIPE & SPAC Combo In The Proteomics Space

In February, Quantum-Si Incorporated, a pioneer in next generation semiconductor chip-based proteomics, and HighCape Capital Acquisition Corp., a special purpose acquisition company sponsored by HighCape Capital LP, announced a business combination agreement. Upon completion of the transaction, the combined company’s Class A common stock is expected to be traded on The Nasdaq Stock Market (“Nasdaq”) … Read more

Insitro To Drive Drug Discovery With Machine Learning

Insitro To Drive Drug Discovery With Machine Learning

Insitro, an early-stage company based in South San Fracisco, CA, is a data-driven drug discovery and development company using machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company is applying state-of-the-art technologies from bioengineering to create massive data sets that enable the power of modern … Read more

Olive AI: At The Intersection Of Healthcare and Robotic Process Automation

Olive AI: At The Intersection Of Healthcare and Robotic Process Automation

The typical physician’s office visit is the closest most Americans will come to experiencing the conditions that characterized the waste and futility of the Soviet Union. Olive AI, a private company based in Columbus, Ohio, intends to fix the problem of massive inefficiency in the U.S. healthcare industry by addressing healthcare’s most burdensome issues — … Read more

What Illumina Ventures’ Portfolio Says About The Science And Business Models Of The Future Care Delivery System

What Illumina Ventures’ Portfolio Says About The Science And Business Models Of The Future Care Delivery System

A look inside a leading venture capital firm’s portfolio is like a lens for understanding the current state of the future of healthcare. Illumina Ventures’ is an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, Inc. The portfolio illustrates as much about business models as it does about the science behind synthetic biology. … Read more

This Chinese Biotech Is Developing A Immune-privileged Cell And Organ Platform

This Chinese Biotech Is Developing A Immune-privileged Cell And Organ Platform

Hangzhou Qihan Biotechnology Co., Ltd. is innovating in transplantable cells, tissues, and organs to solve the massive organ shortage crisis. The company targets the scientific challenge of specific cell therapy by developing a multiplexable high-throughout gene-editing platform. The platform’s key feature is to reduce the immunogenicity of human stem cells, thus limiting their ability to … Read more

This Chinese Cloud Company To Expand Its Clinical Trails Software With $176 Million VC Financing

This Chinese Cloud Company To Expand Its Clinical Trails Software With $176 Million VC Financing

Taimei Technology of Shanghai completed a $176 million financing to support its AI cloud-based suite of programs for clinical trials and drug safety. The company’s SAAS platform enables clinical research collaboration between sponsors, sites, CROs, patients, regulatory agencies and third-party providers. Its latest funding was co-led by Tencent Holdings, GL Ventures (a Hillhouse subsidiary), and YF Capital, … Read more

This Chinese Startup Completes Series B Financing For Oncolytic Virus Development

This Chinese Startup Completes Series B Financing For Oncolytic Virus Development

Immvira Group Company announced this week the completion of series B financing for $58 million. The biotechnology startup focuses on the development of new generation oncolytic viruses as potential cancer therapeutics. Immvirva attracted a number of biotech investors. This round of financing was led by Huagai Capital, with participation by Apricot Capital, Cowin Capital. The funds … Read more